-+ 0.00%
-+ 0.00%
-+ 0.00%

Constellation Brands’ Q2 2027 Earnings: What to Expect

Barchart·09/29/2026 07:33:30
Listen to the news

Constellation Brands, Inc. (STZ) is a New York-based beverage alcohol company that produces and markets beer, wine, and spirits across the U.S., Mexico, New Zealand, and Italy. Its portfolio is led by high-end beer brands such as Modelo Especial, Corona Extra, Pacifico, and Victoria, alongside wine and spirits brands including Kim Crawford, Robert Mondavi Winery, The Prisoner Wine Company, Casa Noble, and High West. With a market cap of $19.4 billion, the company has built a strong position by focusing on high-end, consumer-favored brands and shifting its mix toward faster-growing categories like imported beer.

The beverage titan is expected to announce its second-quarter earnings for 2027 after the market closes on Tuesday, Oct. 6, 2026. Ahead of the event, analysts expect STZ to report a profit of $3.62 per share on a diluted basis, down marginally from $3.63 per share in the year-ago quarter. The company exceeded consensus estimates in each of the last four quarters, which is impressive. 

For the fiscal year that ends in February 2027, analysts expect STZ to report EPS of $11.81, down marginally from $11.82 in fiscal 2026. Moreover, its EPS is expected to rise 3.2% year over year to $12.19 in fiscal 2028.

www.barchart.com

STZ stock has slumped 14.8% over the past year, trailing the S&P 500 Index’s ($SPX) 15.7% gains and the State Street Consumer Staples Select Sector SPDR Fund’s (XLP) 5.5% rise over the same time frame.

www.barchart.com

On Sept. 8, Constellation Brands announced the early redemption of $600 million of its 4.350% senior notes due 2027, with the redemption scheduled for Sept. 18, 2026. The notes will be redeemed for cash, with the exact redemption price determined under the terms of the applicable supplemental indenture. The move allows Constellation to retire a significant portion of its outstanding debt nearly a year ahead of schedule, while the company continues to manage its capital structure and financing costs.

Analysts’ consensus opinion on STZ stock is reasonably bullish, with a “Moderate Buy” rating overall. Out of 24 analysts covering the stock, 10 advise a “Strong Buy” rating, three suggest a “Moderate Buy,” nine give a “Hold,” one advocates a “Moderate Sell,” and the last analyst recommends a “Strong Sell.” STZ’s average analyst price target is $162.04, indicating a potential upside of 43.5% from the current levels. 


On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.